SARDA PROTEINS LTD. - 519242 - Non-Applicability Of Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2024
Please find attached herewith, Declaration with respect to Non-applicability of Disclosure of Related Party Transactions for the half year ended 31st March, 2024. SARDA PROTEINS LTD. - 519242 - Approved Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2024 Along With The Statement Of Assets And Liabilities As On 31St March 2024 And Cash Flow Statement For The Year Ended On 31St March, 2024
In accordance with Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2024 along with the Statement of Assets and Liabilities as on 31st March, 2024 and Statement of Cash Flow for the year ended on 31st March, 2024 and Auditor''s Report issued with unmodified opinion. Further, a declaration duly signed by the Managing Director and the Chief Financial Officer of the company, pursuant to Regulation 33(3)(d) of the Listing Regulations, read with SEBI Circular CIR/CFD/CMD/56/2016 dated May 27, 2016 to the effect that Auditor''s Report has been issued with unmodified opinion on the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2024 is also enclosed herewith. SARDA PROTEINS LTD. - 519242 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, 30Th April, 2024 Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations")
The Board of Directors of the Company in their meeting held on Tuesday, 30th April, 2024 at the corporate office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan) which commenced at 04:00 P.M. and concluded at 06:30 P.M. inter-alia transacted the businesses enclosed herewith. SARDA PROTEINS LTD. - 519242 - Board Meeting Intimation for Meeting To Be Held On Tuesday, 30Th April, 2024 At 04:00 P.M At The Corporate Office Of The Company Situated At Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur 302018 (Rajasthan)
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 ,inter alia, to consider and approve the Audited Financial Results of the company for the quarter and year ended on 31st March, 2024 along with Statement of Assets and Liabilities as on 31st March, 2024 and Statement of Cash Flow for the year ended on 31st March, 2024 and to take on record the Auditor's Report on the Audited Financial Results for the quarter and year ended on 31st March, 2024. SARDA PROTEINS LTD. - 519242 - Compliance Of Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Year Ended On 31St March, 2024
We are enclosing herewith, Compliance Certificate under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended on 31st March, 2024 SARDA PROTEINS LTD. - 519242 - Compliance Certificate For The Year Ended On 31St March, 2024.
We are enclosing herewith, Compliance Certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended on 31st March, 2024. SARDA PROTEINS LTD. - 519242 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We hereby enclose herewith the Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 31st March, 2024 received from M/s Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company. SARDA PROTEINS LTD. - 519242 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company SARDA PROTEINS LTD. 2 CIN NO. L15142RJ1991PLC006353 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* NOT APPLICABLE 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) NOT APPLICABLE 8Quantum of (d), which has been met from (c)(e)* NOT APPLICABLE 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* NOT APPLICABLE Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)NOT APPLICABLE Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-AMIT KUMAR MODIDesignation :-COMPANY SECRETARY AND COMPLIANCE OFFICER Name of the Chief Financial Officer :- SHIPRA GANDHI Designation : -CHIEF FINANCIAL OFFICER Date: 03/04/2024 SARDA PROTEINS LTD. - 519242 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySARDA PROTEINS LTD. 2CIN NO.L15142RJ1991PLC006353 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: AMIT KUMAR MODI Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: [email protected] Name of the Chief Financial Officer: SHIPRA GANDHI Designation: CHIEF FINANCIAL OFFICER EmailId: [email protected] Date: 03/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. SARDA PROTEINS LTD. - 519242 - Closure of Trading Window
This is to inform you that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended) read with the Company''s Code of Conduct to regulate, monitor and report trading, the Trading Window for trading in the securities of the Company shall remain closed for Designated Persons of the Company and their relatives from 01st April, 2024 till 48 hours after the announcement of the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2024. The date of meeting of the Board of Directors to approve the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2024 will be informed in due course.